ActivBiotics' Other Investors

ActivBiotics raised a round of funding on , . Investors include New England Partners.

ActivBiotics is focused on the development and commercialization of antibacterials for the treatment of acute and chronic disease. The Company is developing rifalazil - a potent broad spectrum antibio…

Articles about ActivBiotics' Other Investors: